Immunology: turning basic research into a therapy.
One of the driving forces in the field of immunology is the ambition to translate experimental research into novel useful therapies. Therefore, the aim of this mini-review is to exemplify emerging therapies as well as highlight hurdles that need to be overcome before they can be introduced into the clinic.
Leishman
Andrew J
AJ
Discovery BioScience, AstraZeneca R and D Charnwood, Bakewell Road Loughborough, LE11 5RH, UK. Andrew.Leishman@astrazeneca.com
Bundick
Robert V
RV
D000818:Animals; D035843:Biomedical Research / Q000639:trends; D016207:Cytokines / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000494:pharmacology; D003713:Dendritic Cells / Q000276:immunology / Q000637:transplantation; D006801:Humans; D007167:Immunotherapy / Q000639:trends; D013601:T-Lymphocytes / Q000166:cytology / Q000276:immunology / Q000637:transplantation; D014612:Vaccines / Q000276:immunology
D016207:Cytokines; D014612:Vaccines